Postmenopausal Women Need More GH Secretagogue Stimulation Even With Estrogen Replacement
Even with estradiol replacement, postmenopausal women had reduced GH and IGF-1 versus premenopausal women when stimulated with combined GHRP + GHRH, suggesting menopause causes irreversible changes in GH axis capacity.
Quick Facts
What This Study Found
Postmenopausal women, even with estradiol replacement, showed reduced fasting GH, IGF-1, and diminished dual-secretagogue GH burst response compared to premenopausal women — suggesting irreversible menopausal GH axis changes.
Key Numbers
How They Did This
Clinical trial comparing postmenopausal (with E2 replacement) and premenopausal women during dual GHRP + GHRH stimulation. GH deconvolution analysis, IGF-1, and burst parameters measured.
Why This Research Matters
If menopause causes irreversible GH axis changes, estrogen replacement alone won't restore youthful GH function. Combined peptide therapy may help but won't fully reverse the age-related decline.
The Bigger Picture
Menopause involves more than estrogen loss — it includes irreversible changes in GH axis capacity. Comprehensive anti-aging endocrinology must address both estrogen AND GH deficits.
What This Study Doesn't Tell Us
Estradiol-matched comparison but other menopausal hormonal changes (progesterone, androgens) not controlled. Small sample inherent to intensive GH profiling.
Questions This Raises
- ?What causes the irreversible GH axis change in menopause?
- ?Can higher peptide doses overcome the menopausal deficit?
- ?Should postmenopausal GH therapy combine estrogen + GH secretagogues?
Trust & Context
- Key Stat:
- Irreversible GH loss Even matching estrogen levels, postmenopausal women produced less GH — menopause causes permanent GH axis changes beyond estrogen deficiency
- Evidence Grade:
- Moderate evidence from an intensive clinical comparison with GH deconvolution analysis in estradiol-controlled conditions.
- Study Age:
- Published in 2004. The irreversibility of menopausal GH axis changes has been further characterized.
- Original Title:
- Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.
- Published In:
- The Journal of clinical endocrinology and metabolism, 89(9), 4746-54 (2004)
- Authors:
- Erickson, Dana(5), Keenan, Daniel M(5), Mielke, Kristi(3), Bradford, Kandace, Bowers, Cyril Y, Miles, John M, Veldhuis, Johannes D
- Database ID:
- RPEP-00910
Evidence Hierarchy
Frequently Asked Questions
Does menopause permanently affect growth hormone?
Yes — this study shows even replacing estrogen doesn't fully restore GH function in postmenopausal women. Menopause causes lasting changes to the GH system beyond just estrogen loss.
What can be done?
GH-releasing peptides can partially compensate, but may not fully restore premenopausal levels. The combination of estrogen + GH secretagogues appears more effective than either alone.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00910APA
Erickson, Dana; Keenan, Daniel M; Mielke, Kristi; Bradford, Kandace; Bowers, Cyril Y; Miles, John M; Veldhuis, Johannes D. (2004). Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.. The Journal of clinical endocrinology and metabolism, 89(9), 4746-54.
MLA
Erickson, Dana, et al. "Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.." The Journal of clinical endocrinology and metabolism, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Dual secretagogue drive of burst-like growth hormone secreti..." RPEP-00910. Retrieved from https://rethinkpeptides.com/research/erickson-2004-dual-secretagogue-drive-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.